Joshua Mathew

YSM Online

Yale-based Targeted Immunotherapies Receive Funding

Yale professor of chemistry David Spiegel and his company Kleo Pharmaceuticals are working to develop drug platforms that could be revolutionary immunotherapies for treating cancer and infectious diseases. “Kleo” is a synthesis of the names of Spiegel’s wife and son.

Read More »